Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Lynx1 Capital Management LP | 10% Owner | 2025-07-24 | 66,423 | $5.71 | $379.47kBuy |
Lynx1 Capital Management LP | 10% Owner | 2025-07-23 | 49,302 | $5.74 | $283.04kBuy |
Lynx1 Capital Management LP | 10% Owner | 2025-07-22 | 13,123 | $5.44 | $71.34kBuy |
Orbimed Advisors LLC | 10% Owner | 2025-06-26 | 213,257 | $0.33 | $70.37kSell |
Orbimed Advisors LLC | 10% Owner | 2025-06-25 | 138,800 | $0.33 | $45.80kSell |
Orbimed Advisors LLC | 10% Owner | 2025-06-24 | 231,600 | $0.35 | $81.06kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-24 | 68,195 | $0.32 | $21.82kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-23 | 89,328 | $0.34 | $30.37kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-22 | 78,049 | $0.34 | $26.54kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-17 | 77,090 | $0.33 | $25.44kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Advisors LLC | 377.94% | 12,013,666 | $91.18M | Insider |
Frazier Life Sciences IX LP | 157.59% | 5,009,219 | $38.02M | Insider |
Patrick J. Heron | 157.59% | 5,009,219 | $38.02M | Insider |
Thomas Woiwode | 156.03% | 4,959,769 | $37.64M | Insider |
Versant Venture Capital VI LP | 156.03% | 4,959,769 | $37.64M | Insider |
Liam Ratcliffe | 82.41% | 2,619,430 | $19.88M | Insider |
New Leaf Venture Partners LLC | 78.58% | 2,497,922 | $18.96M | Institution |
Vanguard Group Inc | 64.19% | 2,040,564 | $15.49M | Institution |
Renaissance Technologies LLC | 44.56% | 1,416,399 | $10.75M | Institution |
Acadian Asset Management LLC | 29.38% | 933,764 | $7.09M | Institution |